Development of highly potent and selective dynorphin A analogues as new medicines

THUIR > College of Science > Department of Chemistry > Periodical Articles > Item 310901/21315

Please use this identifier to cite or link to this item: http://140.128.103.80:8080/handle/310901/21315

Title:	Development of highly potent and selective dynorphin A analogues as new medicines
Authors:	Lung, F.-D.T., Chen, C.-H., Liu, J.-H.
Contributors:	Department of Chemistry, Tunghai University
Keywords:	Dynorphin A;Guinea-pig brain;Guinea-pig ileum;Opioid peptide;The κ-receptor
Date:	2005
Issue Date:	2013-05-14T09:04:51Z (UTC)
Abstract:	Dynorphin A (Dyn A), a 17 amino acid peptide H-Tyr-Gly-Gly-Phe-Leu-Arg-Arg- Ile-Arg-Pro-Lys-Leu-Lys-Trp-Asp-Asn-Gln-OH, is a potent opioid peptide which interacts preferentially with κ-opioid receptors. Research in the development of selective and potent opioid peptide ligands for the κ-receptor is important in mediating analgesia. Several cyclic disulphide bridge-containing peptide analogues of Dyn A, which were conformationally constrained in the putative message or address segment of the opioid ligand, were designed, synthesized and assayed. To further investigate the conformational and topographical requirements for the residues in positions 5 and 11 of these analogues, a systematic series of Dyn A1-11-NH 2 cyclic analogues incorporating the sulphydryl-containing amino acids L- and D-Cys and L- and D-Pen in positions 5 and 11 were synthesized and assayed. Cyclic lactam peptide analogues were also synthesized and assayed. Several of these cyclic analogues, retained the same affinity and selectivity (vs. the ν- and δ-receptors) as the parent Dyn A1-11-NH 2 peptide in the guinea-pig brain (GPB), but exhibited a much lower activity in the guinea-pig ileum (GPI), thus leading to centrally vs. peripherally selective peptides. Studies of the structure-activity relationship of Dyn A peptide provide new insights into the importance of each amino acid residue (and their configurations) in Dyn A analogues for high potency and good selectivity at κ-opioid receptors. We report herein the progress towards the development of Dyn A peptide ligands, which can act as agonists or antagonists at cell surface receptors that modulate cell function and animal behaviour using various approaches to rational peptide ligand-based drug design. ? 2005 The Authors. Journal compilation ? 2005 Blackwell Munksgaard.
Relation:	Journal of Peptide Research 66 (5) , pp. 263-276
Appears in Collections:	[Department of Chemistry ] Periodical Articles

Files in This Item:

File	Size	Format
index.html	0Kb	HTML	132	View/Open

Loading...